Cargando…

Use of Whole-Genome Sequencing to Predict Mycobacterium tuberculosis Complex Drug Resistance from Early Positive Liquid Cultures

Our objective was to evaluate the performance of whole-genome sequencing (WGS) from early positive liquid cultures for predicting Mycobacterium tuberculosis complex (MTBC) drug resistance. Clinical isolates were obtained from tuberculosis patients at Shanghai Pulmonary Hospital (SPH). Antimicrobial...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaocui, Tan, Guangkun, Sha, Wei, Liu, Haican, Yang, Jinghui, Guo, Yinjuan, Shen, Xin, Wu, Zheyuan, Shen, Hongbo, Yu, Fangyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045259/
https://www.ncbi.nlm.nih.gov/pubmed/35311541
http://dx.doi.org/10.1128/spectrum.02516-21
_version_ 1784695275742298112
author Wu, Xiaocui
Tan, Guangkun
Sha, Wei
Liu, Haican
Yang, Jinghui
Guo, Yinjuan
Shen, Xin
Wu, Zheyuan
Shen, Hongbo
Yu, Fangyou
author_facet Wu, Xiaocui
Tan, Guangkun
Sha, Wei
Liu, Haican
Yang, Jinghui
Guo, Yinjuan
Shen, Xin
Wu, Zheyuan
Shen, Hongbo
Yu, Fangyou
author_sort Wu, Xiaocui
collection PubMed
description Our objective was to evaluate the performance of whole-genome sequencing (WGS) from early positive liquid cultures for predicting Mycobacterium tuberculosis complex (MTBC) drug resistance. Clinical isolates were obtained from tuberculosis patients at Shanghai Pulmonary Hospital (SPH). Antimicrobial susceptibility testing (AST) was performed, and WGS from early Bactec mycobacterial growth indicator tube (MGIT) 960-positive liquid cultures was performed to predict the drug resistance using the TB-Profiler informatics platform. A total of 182 clinical isolates were enrolled in this study. Using phenotypic AST as the gold standard, the overall sensitivity and specificity for WGS were, respectively, 97.1% (89.8 to 99.6%) and 90.4% (83.4 to 95.1%) for rifampin, 91.0% (82.4 to 96.3%) and 95.2% (89.1 to 98.4%) for isoniazid, 100.0% (89.4 to 100.0%) and 87.3% (80.8 to 92.1%) for ethambutol, 96.6% (88.3 to 99.6%) and 61.8% (52.6 to 70.4%) for streptomycin, 86.8% (71.9 to 95.6%) and 95.8% (91.2 to 98.5%) for moxifloxacin, 86.5% (71.2 to 91.5%) and 95.2% (90.3 to 98.0%) for ofloxacin, 100.0% (54.1 to 100.0%) and 67.6% (60.2 to 74.5%) for amikacin, 100.0% (63.1 to 100.0%) and 67.2% (59.7 to 74.2%) for kanamycin, 62.5% (24.5 to 91.5%) and 88.5% (82.8 to 92.8%) for ethionamide, 33.3% (4.3 to 77.7%) and 98.3% (95.1 to 99.7%) for para-aminosalicylic acid, and 0.0% (0.0 to 12.3%) and 100.0% (97.6 to 100.0%) for cycloserine. The concordances of WGS-based AST and phenotypic AST were as follows: rifampin (92.9%), isoniazid (93.4%), ethambutol (89.6%), streptomycin (73.1%), moxifloxacin (94.0%), ofloxacin (93.4%), amikacin (68.7%), kanamycin (68.7%), ethionamide (87.4%), para-aminosalicylic acid (96.2%) and cycloserine (84.6%). We conclude that WGS could be a promising approach to predict MTBC resistance from early positive liquid cultures. IMPORTANCE In this study, we used whole-genome sequencing (WGS) from early positive liquid (MGIT) cultures instead of solid cultures to predict drug resistance of 182 Mycobacterium tuberculosis complex (MTBC) clinical isolates to predict drug resistance using the TB-Profiler informatics platform. Our study indicates that WGS may be a promising method for predicting MTBC resistance using early positive liquid cultures.
format Online
Article
Text
id pubmed-9045259
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-90452592022-04-28 Use of Whole-Genome Sequencing to Predict Mycobacterium tuberculosis Complex Drug Resistance from Early Positive Liquid Cultures Wu, Xiaocui Tan, Guangkun Sha, Wei Liu, Haican Yang, Jinghui Guo, Yinjuan Shen, Xin Wu, Zheyuan Shen, Hongbo Yu, Fangyou Microbiol Spectr Research Article Our objective was to evaluate the performance of whole-genome sequencing (WGS) from early positive liquid cultures for predicting Mycobacterium tuberculosis complex (MTBC) drug resistance. Clinical isolates were obtained from tuberculosis patients at Shanghai Pulmonary Hospital (SPH). Antimicrobial susceptibility testing (AST) was performed, and WGS from early Bactec mycobacterial growth indicator tube (MGIT) 960-positive liquid cultures was performed to predict the drug resistance using the TB-Profiler informatics platform. A total of 182 clinical isolates were enrolled in this study. Using phenotypic AST as the gold standard, the overall sensitivity and specificity for WGS were, respectively, 97.1% (89.8 to 99.6%) and 90.4% (83.4 to 95.1%) for rifampin, 91.0% (82.4 to 96.3%) and 95.2% (89.1 to 98.4%) for isoniazid, 100.0% (89.4 to 100.0%) and 87.3% (80.8 to 92.1%) for ethambutol, 96.6% (88.3 to 99.6%) and 61.8% (52.6 to 70.4%) for streptomycin, 86.8% (71.9 to 95.6%) and 95.8% (91.2 to 98.5%) for moxifloxacin, 86.5% (71.2 to 91.5%) and 95.2% (90.3 to 98.0%) for ofloxacin, 100.0% (54.1 to 100.0%) and 67.6% (60.2 to 74.5%) for amikacin, 100.0% (63.1 to 100.0%) and 67.2% (59.7 to 74.2%) for kanamycin, 62.5% (24.5 to 91.5%) and 88.5% (82.8 to 92.8%) for ethionamide, 33.3% (4.3 to 77.7%) and 98.3% (95.1 to 99.7%) for para-aminosalicylic acid, and 0.0% (0.0 to 12.3%) and 100.0% (97.6 to 100.0%) for cycloserine. The concordances of WGS-based AST and phenotypic AST were as follows: rifampin (92.9%), isoniazid (93.4%), ethambutol (89.6%), streptomycin (73.1%), moxifloxacin (94.0%), ofloxacin (93.4%), amikacin (68.7%), kanamycin (68.7%), ethionamide (87.4%), para-aminosalicylic acid (96.2%) and cycloserine (84.6%). We conclude that WGS could be a promising approach to predict MTBC resistance from early positive liquid cultures. IMPORTANCE In this study, we used whole-genome sequencing (WGS) from early positive liquid (MGIT) cultures instead of solid cultures to predict drug resistance of 182 Mycobacterium tuberculosis complex (MTBC) clinical isolates to predict drug resistance using the TB-Profiler informatics platform. Our study indicates that WGS may be a promising method for predicting MTBC resistance using early positive liquid cultures. American Society for Microbiology 2022-03-21 /pmc/articles/PMC9045259/ /pubmed/35311541 http://dx.doi.org/10.1128/spectrum.02516-21 Text en Copyright © 2022 Wu et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Wu, Xiaocui
Tan, Guangkun
Sha, Wei
Liu, Haican
Yang, Jinghui
Guo, Yinjuan
Shen, Xin
Wu, Zheyuan
Shen, Hongbo
Yu, Fangyou
Use of Whole-Genome Sequencing to Predict Mycobacterium tuberculosis Complex Drug Resistance from Early Positive Liquid Cultures
title Use of Whole-Genome Sequencing to Predict Mycobacterium tuberculosis Complex Drug Resistance from Early Positive Liquid Cultures
title_full Use of Whole-Genome Sequencing to Predict Mycobacterium tuberculosis Complex Drug Resistance from Early Positive Liquid Cultures
title_fullStr Use of Whole-Genome Sequencing to Predict Mycobacterium tuberculosis Complex Drug Resistance from Early Positive Liquid Cultures
title_full_unstemmed Use of Whole-Genome Sequencing to Predict Mycobacterium tuberculosis Complex Drug Resistance from Early Positive Liquid Cultures
title_short Use of Whole-Genome Sequencing to Predict Mycobacterium tuberculosis Complex Drug Resistance from Early Positive Liquid Cultures
title_sort use of whole-genome sequencing to predict mycobacterium tuberculosis complex drug resistance from early positive liquid cultures
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045259/
https://www.ncbi.nlm.nih.gov/pubmed/35311541
http://dx.doi.org/10.1128/spectrum.02516-21
work_keys_str_mv AT wuxiaocui useofwholegenomesequencingtopredictmycobacteriumtuberculosiscomplexdrugresistancefromearlypositiveliquidcultures
AT tanguangkun useofwholegenomesequencingtopredictmycobacteriumtuberculosiscomplexdrugresistancefromearlypositiveliquidcultures
AT shawei useofwholegenomesequencingtopredictmycobacteriumtuberculosiscomplexdrugresistancefromearlypositiveliquidcultures
AT liuhaican useofwholegenomesequencingtopredictmycobacteriumtuberculosiscomplexdrugresistancefromearlypositiveliquidcultures
AT yangjinghui useofwholegenomesequencingtopredictmycobacteriumtuberculosiscomplexdrugresistancefromearlypositiveliquidcultures
AT guoyinjuan useofwholegenomesequencingtopredictmycobacteriumtuberculosiscomplexdrugresistancefromearlypositiveliquidcultures
AT shenxin useofwholegenomesequencingtopredictmycobacteriumtuberculosiscomplexdrugresistancefromearlypositiveliquidcultures
AT wuzheyuan useofwholegenomesequencingtopredictmycobacteriumtuberculosiscomplexdrugresistancefromearlypositiveliquidcultures
AT shenhongbo useofwholegenomesequencingtopredictmycobacteriumtuberculosiscomplexdrugresistancefromearlypositiveliquidcultures
AT yufangyou useofwholegenomesequencingtopredictmycobacteriumtuberculosiscomplexdrugresistancefromearlypositiveliquidcultures